A proof-of-concept on transcription factor EL222 bioconjugation for targeted DNA cleavage.
The development of site-specific artificial nucleases remains a significant challenge in chemical biology. Here, we report the design and biophysical characterization of a light-responsive protein-small molecule hybrid based on the EL222 transcription factor. Through protein bioconjugation, we converted the native LOV-...